Clinical Trial Update: NeuroPsyBiT-BD Omics: Genomic & Epigenomic Biobank of Bipolar Disorder

View source ↗

Summary

This clinical trial is a genomic and epigenomic biobank study for Bipolar Disorder (NeuroPsyBiT-BD Omics) that is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Snippet

Sponsor: Selçuk State Hospital | Conditions: Bipolar Disorder | Status: NOT_YET_RECRUITING